Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Capitalization (Details)

v3.23.2
Stockholders' Equity and Capitalization (Details) - USD ($)
 6 Months Ended
Feb. 22, 2023
Feb. 16, 2023
Jun. 30, 2023
Feb. 15, 2023
Equity [Line Items]        
Exercise price (in dollars per share)     $ 0.10  
Amended Credit Agreement        
Equity [Line Items]        
Conversion Price (in dollars per share)   $ 0.0386 $ 0.0386 $ 0.40
MTA Warrants, Credit Consideration        
Equity [Line Items]        
Common stock issuance costs   $ 1,597,236 $ 1,597,236  
Warrant        
Equity [Line Items]        
Warrants exercised (in shares)     16,641,486  
Intrinsic value of warrant exercises     $ 332,830  
Exercise warrant (in shares)     16,641,486  
Proceeds from pre-funded warrant exercises     $ 282,905  
2021 Common Stock Warrants to Placement Agent        
Equity [Line Items]        
Exercise price (in dollars per share)     $ 0.11  
2021 Common Stock Warrants to Placement Agent | MTA Warrants, Credit Consideration        
Equity [Line Items]        
Number of shares issued in transaction (in shares)   41,379,164 41,379,164  
2021 Common Stock Warrants to Placement Agent | MTA Warrants        
Equity [Line Items]        
Number of shares issued in transaction (in shares) 16,641,486 16,641,486    
Exercise price (in dollars per share)   $ 0.017    
Common Stock Warrants | MTA Warrants        
Equity [Line Items]        
Exercise price (in dollars per share)   $ 282,905 $ 282,905